# Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

> **NCT01987752** · — · COMPLETED · sponsor: **Allergan** · enrollment: 732 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DRUG:** brimonidine tartrate/timolol maleate Ophthalmic Solution

## Key facts

- **NCT ID:** NCT01987752
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 732 (ACTUAL)
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01987752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01987752, "Safety and Efficacy of Combigan® Ophthalmic Solution in Korea". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01987752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*